Validation of dominant and secondary sequence utilization in PI-RADS v2 for classifying prostatic lesions.
CONCLUSIONS: Upgraded PI-RADS 4 and true 4 targets have a higher odds of detecting GG1+ and GG2+ compared to PI-RADS 3 in the PZ and TZ. Our findings validate the revised scoring system for PI-RADS.
PMID: 31180306 [PubMed - in process]
Source: Canadian Journal of Urology - Category: Urology & Nephrology Tags: Can J Urol Source Type: research
More News: Canada Health | Cancer | Cancer & Oncology | Prostate Cancer | Transitional Cell Carcinoma | Urology & Nephrology